Canada Proposes Tiered Risk Framework For Regulating Self-Care Items
This article was originally published in The Rose Sheet
Marketers of traditional medicines and homeopathic products could have a harder time using health claims under Health Canada’s proposal for regulating “self-care” products. At the same time, the revised framework would grease the path to market for some dietary supplements and OTC drugs, while cosmetics requirements would be largely unaffected.
You may also be interested in...
Health Canada says its planned overhaul will not scrap the current natural health product framework, but industry is skeptical. In a Council for Responsible Nutrition webinar, an industry consultant says marketers of OTC drugs, supplements and cosmetics are discussing the proposal's negative implications with the agency.
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.